Healthcare provider profile · identity verified

Suzanne Korum, ARNP-BC

Nurse Practitioner · PALM COAST, FL · NPI 1093149569

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	316	157
Losartan Potassium	Losartan Potassium	296	134
Atorvastatin Calcium	Atorvastatin Calcium	247	120
Levothyroxine Sodium	Levothyroxine Sodium	182	80
Rosuvastatin Calcium	Rosuvastatin Calcium	179	89
Methylprednisolone	Methylprednisolone	152	133
Metformin Hcl	Metformin Hcl	124	62
Omeprazole	Omeprazole	124	73
Lisinopril	Lisinopril	120	59
Gabapentin	Gabapentin	98	48
Metoprolol Succinate	Metoprolol Succinate	98	45
Albuterol Sulfate Hfa	Albuterol Sulfate	89	46
Furosemide	Furosemide	89	51
Pantoprazole Sodium	Pantoprazole Sodium	77	47
Ciprofloxacin Hcl	Ciprofloxacin Hcl	69	63
Metoprolol Tartrate	Metoprolol Tartrate	69	35
Eliquis	Apixaban	66	32
Carvedilol	Carvedilol	64	31
Tamsulosin Hcl	Tamsulosin Hcl	64	34
Fluticasone Propionate	Fluticasone Propionate	62	33
Hydrochlorothiazide	Hydrochlorothiazide	62	33
Simvastatin	Simvastatin	55	23
Clopidogrel	Clopidogrel Bisulfate	50	25
Allopurinol	Allopurinol	48	22
Famotidine	Famotidine	47	23
Sertraline Hcl	Sertraline Hcl	46	24
Amoxicillin	Amoxicillin	45	40
Potassium Chloride	Potassium Chloride	44	22
Buspirone Hcl	Buspirone Hcl	43	23
Jardiance	Empagliflozin	43	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	19
Azithromycin	Azithromycin	40	38
Alprazolam	Alprazolam	39	12
Montelukast Sodium	Montelukast Sodium	38	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	17
Fenofibrate	Fenofibrate	37	21
Trazodone Hcl	Trazodone Hcl	35	22
Hydralazine Hcl	Hydralazine Hcl	34	18
Ozempic	Semaglutide	34	14
Tizanidine Hcl	Tizanidine Hcl	33	20
Doxycycline Monohydrate	Doxycycline Monohydrate	32	28
Escitalopram Oxalate	Escitalopram Oxalate	31	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	15
Alendronate Sodium	Alendronate Sodium	30	18
Duloxetine Hcl	Duloxetine Hcl	29	15
Atenolol	Atenolol	28	15
Januvia	Sitagliptin Phosphate	28	11
Symbicort	Budesonide/Formoterol Fumarate	28	14
Xarelto	Rivaroxaban	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	11
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Ezetimibe	Ezetimibe	25	14
Glimepiride	Glimepiride	25	12
Meloxicam	Meloxicam	25	19
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Mirtazapine	Mirtazapine	23	13
Prednisone	Prednisone	23	14
Fluoxetine Hcl	Fluoxetine Hcl	22	11
Finasteride	Finasteride	20	11
Mupirocin	Mupirocin	20	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	16
Metformin Hcl Er	Metformin Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	11
Azelastine Hcl	Azelastine Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Metronidazole	Metronidazole	13	13
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	13	12
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Ramipril	Ramipril	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Clonidine Hcl	Clonidine Hcl	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Glipizide	Glipizide	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Digoxin	Digoxin	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error